NovoCIB Overview
- Founded
- 2005
- Status
- Private
- Latest Deal Type
- Angel
- Latest Deal Amount
- $260K
- Investors
- 1
NovoCIB General Information
Description
Provider of innovative enzyme activity assay kits for life scientists and for food quality control. The company produces recombinant enzymes of purine metabolism and also provides analytical services for nucleotide quantification, thereby providing the food industry with rich sources of validated or high-potential targets in oncology, infectiology and immunology.
Contact Information
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Primary Office
- 115, Avenue Lacassagne
- 69003 Lyon
- France
+33 04 00 00 00 00
NovoCIB Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 1. Angel (individual) | 01-Nov-2012 | $260K | 00000 | Completed | Generating Revenue |
NovoCIB Patents
NovoCIB Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| FR-2935003-A1 | New ultrasensitive and rapid method for measuring by bioluminescence the degree of freshness of animal flesh | Pending | 14-Aug-2008 | 00000000 |
NovoCIB Executive Team (2)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Larissa Balakireva | Co-Founder, Chief Scientific Officer, Chief Executive Officer & President | ||
| Nicolas Godard | General Manager & Co-Founder |
NovoCIB Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| Savoie Angels | Angel Group | Minority | 000 0000 | 000000 0 |